RU94024111A - Method of intestine infection prophylaxis - Google Patents

Method of intestine infection prophylaxis

Info

Publication number
RU94024111A
RU94024111A RU94024111/14A RU94024111A RU94024111A RU 94024111 A RU94024111 A RU 94024111A RU 94024111/14 A RU94024111/14 A RU 94024111/14A RU 94024111 A RU94024111 A RU 94024111A RU 94024111 A RU94024111 A RU 94024111A
Authority
RU
Russia
Prior art keywords
kefir
acipol
medicine
days
day
Prior art date
Application number
RU94024111/14A
Other languages
Russian (ru)
Other versions
RU2097050C1 (en
Inventor
Л.В. Феклисова
В.А. Новокшонова
Е.Р. Мескина
А.И. Покатилова
Т.М. Юрина
Original Assignee
Московский областной научно-исследовательский клинический институт
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Московский областной научно-исследовательский клинический институт filed Critical Московский областной научно-исследовательский клинический институт
Priority to RU94024111A priority Critical patent/RU2097050C1/en
Publication of RU94024111A publication Critical patent/RU94024111A/en
Application granted granted Critical
Publication of RU2097050C1 publication Critical patent/RU2097050C1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

FIELD: medicine, pediatrics. SUBSTANCE: method involves internal administration of polycomponent biological bacterial preparation "Acipol" containing acidophilic lactobacilli that shows high biochemical, acid-forming and antagonistic activities and the heated kefir fungi (kefir fungus polysaccharide) determining the immunomodulating effect of preparation, 5 doses, once per a day, for 10 days. EFFECT: enhanced effectiveness.

Claims (1)

Изобретение относится к медицине, в частности к профилактике инфекций у детей. Целью изобретения является снижение заболеваемости кишечными инфекциями с одновременным повышением антиинфекционной резистентности и оздоровлением организма. Указанная цель достигается энтеральным введением поликомпонентного биологического бактерийного препарата "Аципол", содержащего ацидофильные лактобактерии с высокой биохимической, кислотообразующей и антагонистической активностью, а также прогретые кефирные грибки (полисахарид кефирных грибков), определяющей иммуномодулирующее действие препарата, по 5 доз один раз в день в течение 10 дней.The invention relates to medicine, in particular to the prevention of infections in children. The aim of the invention is to reduce the incidence of intestinal infections while increasing anti-infectious resistance and healing the body. This goal is achieved by the enteral administration of the multicomponent biological bacterial preparation "Acipol" containing acidophilic lactobacilli with high biochemical, acid-forming and antagonistic activity, as well as heated kefir fungi (kefir fungus polysaccharide), which determines the immunomodulatory effect of the drug, for 5 doses once a day for 5 times 10 days.
RU94024111A 1994-06-28 1994-06-28 Method of enteric infection prophylaxis RU2097050C1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU94024111A RU2097050C1 (en) 1994-06-28 1994-06-28 Method of enteric infection prophylaxis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU94024111A RU2097050C1 (en) 1994-06-28 1994-06-28 Method of enteric infection prophylaxis

Publications (2)

Publication Number Publication Date
RU94024111A true RU94024111A (en) 1997-04-10
RU2097050C1 RU2097050C1 (en) 1997-11-27

Family

ID=20157765

Family Applications (1)

Application Number Title Priority Date Filing Date
RU94024111A RU2097050C1 (en) 1994-06-28 1994-06-28 Method of enteric infection prophylaxis

Country Status (1)

Country Link
RU (1) RU2097050C1 (en)

Also Published As

Publication number Publication date
RU2097050C1 (en) 1997-11-27

Similar Documents

Publication Publication Date Title
GR1002451B (en) Anti-inflamatory compositions containing herbal-based active ingredients, methods of preparing same and uses of same for medical and veterinary purposes.
PL366049A1 (en) Nutritional composition
RU95106639A (en) Method of treatment of bacterial infection, use of azitromycin for medicinal form making
CA2172245A1 (en) Method of treating gram-negative bacterial infection by administration of bactericidal/permeability-increasing (bpi) protein
BR9510423A (en) Low rigidity multilamellar liposomal formulation The process of treating or prophylaxis a bacterial infection in an animal and a mucoid variant thereof, using the antibacterial liposomal formulation
CN1074931C (en) Antimicrobial agent for staphylococcus
WO2000012049A3 (en) A method for the treatment of staphylococcal disease
ATE259654T1 (en) PHARMACEUTICAL PREPARATIONS FOR THE CONTROL OR PROPHYLAXIS OF SURFACES INFECTED BY MICROORGANISMS
CA2382887A1 (en) Immunopotentiating compositions
RU94024111A (en) Method of intestine infection prophylaxis
Kenna Microbiology of chronic suppurative otitis media in children
DE69739775D1 (en) Administration of products of the 5-lipoxygenase synthesis pathway for the treatment of microbial infections
WO2000016786A3 (en) Oxihumic acid and its use in the treatment of various conditions
DE602004017586D1 (en) MEDICAL COMPOSITION FOR THE TREATMENT OF INFECTIONS WITH DRUG-RESISTANT STAPHYLOCOCCUS AUREUS
GR3004655T3 (en)
RU94024117A (en) Method of gastroenterocolitis treatment
RU2181594C2 (en) Method to treat lip infections and fractures of labial red edge in children and youngsters
Riggins et al. Antibiotic and chemotherapy of tuberculosis
CA2199255A1 (en) Enteral vaccine for vaginal infections
FR2307542A1 (en) Immuno-stimulant preparations for human and veterinary use - contg. a mixture of inactivated and lysed bacterial cells
DE10118776A1 (en) Medicinal use of vinegar for killing bacteria, mold fungi, yeasts and acid-labile viruses, e.g. by skin treatment, inhalation, gargling or intestinal cleaning
RU2063737C1 (en) Method for correcting leukopenia in cases of acute lymphoblastous leukoses in children
Mago et al. Efficacy of an immunomodulating drug in immunodeficient and immunocompetent mice
RU94039944A (en) Acid-milk product for treating allergy
RU95108774A (en) Method of carbohydrate metabolism correction in human organism